Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: The role of tenascin-C in immune suppression

Journal of Immunology

Volumn 185, Issue 3, 2010, Pages 1450-1459

  Huang, Jyun Yuan ^a   Cheng, Yu Jung ^b   Lin, Yu Ping ^a   Lin, Huan Ching ^a   Su, Chung Chen ^a   Juliano, Rudy ^c   Yang, Bei Chang ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; COLLAGEN TYPE 4; CYCLIC AMP DEPENDENT PROTEIN KINASE; FIBRONECTIN; FOCAL ADHESION KINASE; INTEGRIN; LAMININ GAMMA1; MITOGEN ACTIVATED PROTEIN KINASE; SHORT HAIRPIN RNA; TENASCIN;

ARTICLE; CELL ADHESION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOCYTE MIGRATION; MONOLAYER CULTURE; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; WESTERN BLOTTING; CELL CULTURE; CELL MOTION; CELL POLARITY; CELL STRAIN HEPG2; CONFOCAL MICROSCOPY; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; MIGRATION INHIBITION; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MIGRATION INHIBITION; CELL MOVEMENT; CELL POLARITY; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HEP G2 CELLS; HUMANS; IMMUNE TOLERANCE; JURKAT CELLS; MICROSCOPY, CONFOCAL; T-LYMPHOCYTE SUBSETS; TENASCIN;

EID: 77956416659     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901352     Document Type: Article

References (46)

1. Curiel, T. J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J. R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942-949.
2. Hiraoka, K., M. Miyamoto, Y. Cho, M. Suzuoki, T. Oshikiri, Y. Nakakubo, T. Itoh, T. Ohbuchi, S. Kondo, and H. Katoh. 2006. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-smallcell lung carcinoma. Br. J. Cancer 94: 275-280. (Pubitemid 43151547)
3. Liakou, C. I., S. Narayanan, D. Ng Tang, C. J. Logothetis, and P. Sharma. 2007. Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. Cancer Immun. 7: 10-16.
4. Schumacher, K., W. Haensch, C. Röefzaad, and P. M. Schlag. 2001. Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res. 61: 3932-3936.
5. Galon, J., A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce- Pagès, M. Tosolini, M. Camus, A. Berger, P.Wind, et al. 2006. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964. (Pubitemid 44498003)
6. Zhang, L., J. R. Conejo-Garcia, D. Katsaros, P. A. Gimotty, M. Massobrio, G. Regnani, A. Makrigiannakis, H. Gray, K. Schlienger, M. N. Liebman, et al. 2003. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348: 203-213.
7. Reddig, P. J., and R. L. Juliano. 2005. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 24: 425-439.
8. Hehlgans, S., M. Haase, and N. Cordes. 2007. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim. Biophys. Acta 1775: 163-180.
9. Su, C. C., Y. P. Lin, Y. J. Cheng, J. Y. Huang, W. J. Chuang, Y. S. Shan, and B. C. Yang. 2007. Phosphatidylinositol 3-kinase/Akt activation by integrin-tumor matrix interaction suppresses Fas-mediated apoptosis in T cells. J. Immunol. 179: 4589-4597.
10. Górski, A., J. Piekarczyk, H. Skurzak, M. Nowaczyk, B. Dybowska, B. Stepień-Sopniewska, G. Korczak-Kowalska, J. Pazdur, and A. Filipowicz-Sosnowska. 1993. Abnormalities in T cell interactions with the extracellular matrix proteins in a patient with Wegener's granulomatosis. Clin. Immunol. Immunopathol. 69: 149-154.
11. Torimura, T., T. Ueno, S. Inuzuka, M. Tanaka, H. Abe, and K. Tanikawa. 1991. Mechanism of fibrous capsule formation surrounding hepatocellular carcinoma. Immunohistochemical study. Arch. Pathol. Lab. Med. 115: 365-371.
12. Menon, A. G., G. J. Fleuren, E. A. Alphenaar, L. E. Jonges, C. M. Janssen van Rhijn, N. G. Ensink, H. Putter, R. A. Tollenaar, C. J. van de Velde, and P. J. Kuppen. 2003. A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer. Cancer Immunol. Immunother. 52: 121-126.
13. Schaumburg-Lever, G., I. Lever, B. Fehrenbacher, H. Möller, B. Bischof, E. Kaiserling, C. Garbe, and G. Rassner. 2000. Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy. J. Cutan. Pathol. 27: 67-75.
14. Ratner, S. 1992. Lymphocyte migration through extracellular matrix. Invasion Metastasis 12: 82-100.
15. Yang, Q., S. Goding, M. Hagenaars, T. Carlos, P. Albertsson, P. Kuppen, U. Nannmark, M. E. Hokland, and P. H. Basse. 2006. Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells. Cancer Immunol. Immunother. 55: 699-707.
16. Edwards, S., P. F. Lalor, C. Tuncer, and D. H. Adams. 2006. Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an alpha v beta3-independent manner. Br. J. Cancer 95: 1545-1554.
17. Rickert, P., O. D. Weiner, F. Wang, H. R. Bourne, and G. Servant. 2000. Leukocytes navigate by compass: roles of PI3Kgamma and its lipid products. Trends Cell Biol. 10: 466-473.
18. Srinivasan, S., F. Wang, S. Glavas, A. Ott, F. Hofmann, K. Aktories, D. Kalman, and H. R. Bourne. 2003. Rac and Cdc42 play distinct roles in regulating PI (3,4,5)P3 and polarity during neutrophil chemotaxis. J. Cell Biol. 160: 375-385.
19. Howe, A. K., and R. L. Juliano. 2000. Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nat. Cell Biol. 2: 593-600.
20. Hecht, I., L. Cahalon, R. Hershkoviz, A. Lahat, S. Franitza, and O. Lider. 2003. Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis. Int. Immunol. 15: 29-38.
21. Woods, M. L., and Y. Shimizu. 2001. Signaling networks regulating beta1 integrin-mediated adhesion of T lymphocytes to extracellular matrix. J. Leukoc. Biol. 69: 874-880.
22. Giese, A., M. D. Rief, M. A. Loo, and M. E. Berens. 1994. Determinants of human astrocytoma migration. Cancer Res. 54: 3897-3904.
23. Kim, S. J., J. H. Park, J. E. Lee, J. M. Kim, J. B. Lee, S. Y. Moon, S. I. Roh, C. G. Kim, and H. S. Yoon. 2004. Effects of type IV collagen and laminin on the cryopreservation of human embryonic stem cells. [Published retraction appears in 2006. Stem Cells 24: 804.] Stem Cells 22: 950-961.
24. Kikkawa, Y., N. Sanzen, and K. Sekiguchi. 1998. Isolation and characterization of laminin-10/11 secreted by human lung carcinoma cells. laminin-10/11 mediates cell adhesion through integrin alpha3 beta1. J. Biol. Chem. 273: 15854-15859.
25. Mighell, A. J., J. Thompson, W. J. Hume, A. F. Markham, and P. A. Robinson. 1997. Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int. J. Cancer 72: 236-240.
26. Baratelli, F., Y. Lin, L. Zhu, S. C. Yang, N. Heuzé-Vourc'h, G. Zeng, K. Reckamp, M. Dohadwala, S. Sharma, and S. M. Dubinett. 2005. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol. 175: 1483-1490.
27. Kuznetsova, S. A., and D. D. Roberts. 2004. Functional regulation of T lymphocytes by modulatory extracellular matrix proteins. Int. J. Biochem. Cell Biol. 36: 1126-1134.
28. Loike, J. D., L. Cao, S. Budhu, S. Hoffman, and S. C. Silverstein. 2001. Blockade of alpha 5 beta 1 integrins reverses the inhibitory effect of tenascin on chemotaxis of human monocytes and polymorphonuclear leukocytes through three-dimensional gels of extracellular matrix proteins. J. Immunol. 166: 7534-7542.
29. Herold-Mende, C., M. M. Mueller, M. M. Bonsanto, H. P. Schmitt, S. Kunze, and H. H. Steiner. 2002. Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int. J. Cancer 98: 362-369.
30. Servant, G., O. D. Weiner, P. Herzmark, T. Balla, J. W. Sedat, and H. R. Bourne. 2000. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 287: 1037-1040.
31. Franca-Koh, J., and P. N. Devreotes. 2004. Moving forward: mechanisms of chemoattractant gradient sensing. Physiology (Bethesda) 19: 300-308.
32. Fischer, D., M. Brown-Lüdi, T. Schulthess, and R. Chiquet-Ehrismann. 1997. Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth. J. Cell Sci. 110: 1513-1522. (Pubitemid 27326669)
33. Orend, G. 2005. Potential oncogenic action of tenascin-C in tumorigenesis. Int. J. Biochem. Cell Biol. 37: 1066-1083.
34. Hauzenberger, D., P. Olivier, D. Gundersen, and C. Rüegg. 1999. Tenascin-C inhibits beta1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1-5 repeats to fibronectin. Eur. J. Immunol. 29: 1435-1447.
35. Mackie, E. J., and R. P. Tucker. 1999. The tenascin-C knockout revisited. J. Cell Sci. 112: 3847-3853.
36. Shan, X., M. J. Czar, S. C. Bunnell, P. Liu, Y. Liu, P. L. Schwartzberg, and R. L. Wange. 2000. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol. Cell. Biol. 20: 6945-6957.
37. Lorenowicz, M. J., M. Fernandez-Borja, and P. L. Hordijk. 2007. cAMP signaling in leukocyte transendothelial migration. Arterioscler. Thromb. Vasc. Biol. 27: 1014-1022.
38. Huang, W., R. Chiquet-Ehrismann, J. V. Moyano, A. Garcia-Pardo, and G. Orend. 2001. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res. 61: 8586-8594. (Pubitemid 33131143)
39. Orend, G., W. Huang, M. A. Olayioye, N. E. Hynes, and R. Chiquet-Ehrismann. 2003. Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4. Oncogene 22: 3917-3926. (Pubitemid 36819665)
40. Chiquet-Ehrismann, R., and M. Chiquet. 2003. Tenascins: regulation and putative functions during pathological stress. J. Pathol. 200: 488-499. (Pubitemid 36818249)
41. Midwood, K. S., and J. E. Schwarzbauer. 2002. Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways. Mol. Biol. Cell 13: 3601-3613.
42. Wierzbicka-Patynowski, I., and J. E. Schwarzbauer. 2003. The ins and outs of fibronectin matrix assembly. J. Cell Sci. 116: 3269-3276.
43. Kaneider, N. C., C. M. Reinisch, S. Dunzendorfer, J. Römisch, C. J. Wiedermann, and C. J. Wiederman. 2002. Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. [Published erratum appears in 2002. J. Cell Sci. 115: 454.] J. Cell Sci. 115: 227-236.
44. Yamashita, Y., K. Oritani, E. K.Miyoshi, R.Wall, M. Bernfield, and P.W. Kincade. 1999. Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. J. Immunol. 162: 5940-5948. (Pubitemid 29314949)
45. Giometto, B., F. Bozza, F. Faresin, L. Alessio, S. Mingrino, and B. Tavolato. 1996. Immune infiltrates and cytokines in gliomas. Acta Neurochir. (Wien) 138: 50-56.
46. Walker, D. G., T. Chuah, M. J. Rist, and M. P. Pender. 2006. T-cell apoptosis in human glioblastoma multiforme: implications for immunotherapy. J. Neuroimmunol. 175: 59-68.